raia drogasil s.a. - RADLY

RADLY

Close Chg Chg %
3.31 -0.32 -9.67%

Closed Market

2.99

-0.32 (9.67%)

Volume: 1.25K

Last Updated:

May 8, 2025, 3:27 PM EDT

Company Overview: raia drogasil s.a. - RADLY

RADLY Key Data

Open

$2.99

Day Range

2.98 - 2.99

52 Week Range

2.59 - 14.00

Market Cap

$4.93B

Shares Outstanding

1.71B

Public Float

N/A

Beta

0.84

Rev. Per Employee

N/A

P/E Ratio

25.36

EPS

$0.13

Yield

92.69%

Dividend

$0.01

EX-DIVIDEND DATE

Dec 12, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

10.09K

 

RADLY Performance

1 Week
 
-9.12%
 
1 Month
 
-19.45%
 
3 Months
 
-16.71%
 
1 Year
 
-40.20%
 
5 Years
 
N/A
 

RADLY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 13
Full Ratings ➔

About raia drogasil s.a. - RADLY

Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its stores are supplied by distribution centers located in the states of São Paulo, Rio de Janeiro, Minas Gerais, Paraná, Goiás, Pernambuco, and Bahia. The company was founded in 1905 and is headquartered in Butanta, Brazil.

RADLY At a Glance

Raia Drogasil SA
Avenue Corifeu de Azevedo Marques
Butanta, Sao Paulo 05339-000
Phone 55-11-3769-5678 Revenue 7.21B
Industry Drugstore Chains Net Income 222.57M
Sector Retail Trade 2024 Sales Growth 6.01%
Fiscal Year-end 12 / 2025 Employees 64,758
View SEC Filings

RADLY Valuation

P/E Current 25.356
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 26.378
Price to Sales Ratio 0.817
Price to Book Ratio 5.854
Price to Cash Flow Ratio 11.465
Enterprise Value to EBITDA 8.907
Enterprise Value to Sales 0.979
Total Debt to Enterprise Value 0.177

RADLY Efficiency

Revenue/Employee 111,345.573
Income Per Employee 3,436.952
Receivables Turnover 12.248
Total Asset Turnover 1.841

RADLY Liquidity

Current Ratio 1.382
Quick Ratio 0.467
Cash Ratio 0.059

RADLY Profitability

Gross Margin 25.096
Operating Margin 6.354
Pretax Margin 3.648
Net Margin 3.087
Return on Assets 5.681
Return on Equity 19.631
Return on Total Capital 9.716
Return on Invested Capital 10.086

RADLY Capital Structure

Total Debt to Total Equity 119.974
Total Debt to Total Capital 54.54
Total Debt to Total Assets 34.354
Long-Term Debt to Equity 95.288
Long-Term Debt to Total Capital 43.318
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Raia Drogasil S.a. - RADLY

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
4.47B 5.63B 6.80B 7.21B
Sales Growth
+14.93% +25.88% +20.85% +6.01%
Cost of Goods Sold (COGS) incl D&A
3.38B 4.21B 5.09B 5.40B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
239.49M 285.28M 332.61M 334.19M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+13.61% +24.67% +20.98% +6.09%
Gross Income
1.10B 1.42B 1.71B 1.81B
Gross Income Growth
+19.20% +29.61% +20.45% +5.76%
Gross Profit Margin
+24.51% +25.24% +25.15% +25.10%
2021 2022 2023 2024 5-year trend
SG&A Expense
850.03M 1.08B 1.31B 1.37B
Research & Development
- - - -
-
Other SG&A
850.03M 1.08B 1.31B 1.37B
SGA Growth
+15.16% +27.16% +20.97% +4.93%
Other Operating Expense
(13.93M) (20.65M) (32.78M) (20.67M)
Unusual Expense
3.61M 5.49M 12.03M 20.19M
EBIT after Unusual Expense
256.22M 354.71M 424.08M 437.94M
Non Operating Income/Expense
(14.23M) (19.72M) (37.14M) (28.20M)
Non-Operating Interest Income
1.77M 5.48M 10.58M 6.69M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
58.83M 103.79M 140.84M 146.72M
Interest Expense Growth
+2.17% +76.42% +35.69% +4.17%
Gross Interest Expense
58.83M 103.79M 140.84M 146.72M
Interest Capitalized
- - - -
-
Pretax Income
183.16M 231.20M 246.09M 263.02M
Pretax Income Growth
+51.35% +26.22% +6.44% +6.88%
Pretax Margin
+4.10% +4.11% +3.62% +3.65%
Income Tax
41.35M 34.51M 25.94M 38.51M
Income Tax - Current - Domestic
41.00M 40.82M 62.97M 60.89M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
348.39K (6.31M) (37.03M) (22.37M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
141.61M 196.53M 217.65M 224.70M
Minority Interest Expense
2.26M 3.65M 6.44M 2.13M
Net Income
139.35M 192.88M 211.21M 222.57M
Net Income Growth
+48.37% +38.42% +9.51% +5.38%
Net Margin Growth
+3.12% +3.43% +3.11% +3.09%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
139.35M 192.88M 211.21M 222.57M
Preferred Dividends
- - - -
-
Net Income Available to Common
139.35M 192.88M 211.21M 222.57M
EPS (Basic)
0.0812 0.1126 0.1246 0.135
EPS (Basic) Growth
+48.18% +38.67% +10.66% +8.35%
Basic Shares Outstanding
1.72B 1.71B 1.70B 1.65B
EPS (Diluted)
0.081 0.1121 0.1246 0.1345
EPS (Diluted) Growth
+48.35% +38.40% +11.15% +7.95%
Diluted Shares Outstanding
1.72B 1.72B 1.70B 1.65B
EBITDA
499.32M 645.48M 768.72M 792.33M
EBITDA Growth
+24.22% +29.27% +19.09% +3.07%
EBITDA Margin
+11.17% +11.47% +11.30% +10.99%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 4.175
Number of Ratings 13 Current Quarters Estimate 0.035
FY Report Date 06 / 2025 Current Year's Estimate 0.125
Last Quarter’s Earnings 0.024 Median PE on CY Estimate N/A
Year Ago Earnings 0.127 Next Fiscal Year Estimate 0.161
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 11 10
Mean Estimate 0.04 0.03 0.12 0.16
High Estimates 0.04 0.03 0.16 0.20
Low Estimate 0.03 0.03 0.12 0.15
Coefficient of Variance 3.60 3.61 11.82 9.11

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 8
OVERWEIGHT 0 0 0
HOLD 6 6 5
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Raia Drogasil S.A. in the News